Nystatin

Nyamyc® (Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: Nystatin Cream, USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species.
This cream is not indicated for systemic, oral, intravaginal or ophthalmic use.
How to take it: Adults and Pediatric Patients (Neonates and Older) Apply liberally to affected areas twice daily or as indicated until healing is…
Do not take if: Nystatin cream is contraindicated in patients with a history of hypersensitivity to any of its components.

What it is used for

Nystatin Cream, USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candida species. This cream is not indicated for systemic, oral, intravaginal or ophthalmic use.

How to take it

Adults and Pediatric Patients (Neonates and Older) Apply liberally to affected areas twice daily or as indicated until healing is complete.

Side effects, and when to stop

The frequency of adverse events reported in patients using nystatin cream is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See PRECAUTIONS: General. ) To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Who should not take it

Nystatin cream is contraindicated in patients with a history of hypersensitivity to any of its components.

Warnings

General Nystatin cream should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections. If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Nystatin; [reviewed 2026 Aug 3; cited 2026 Nov 11]. Available from: https://sofidex.com/patients/medicines/nystatin
APA 7th: sofidex. (2026, August 3). Nystatin. Daloreum. Retrieved November 11, 2026, from https://sofidex.com/patients/medicines/nystatin
AMA 11th: Nystatin. sofidex. Reviewed August 3, 2026. Accessed November 11, 2026. https://sofidex.com/patients/medicines/nystatin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.